Drreddys Laboratories | RDY - Trade Creditors


Drreddys Laboratories reported INR36.08B in Trade Creditors for its fiscal quarter ending in September of 2026.





Trade Creditors Change Date
ANI Pharmaceuticals USD 74.41M 585K Sep/2026
Aurora Cannabis CAD 56.83M 47.52M Jun/2026
Bayer EUR 6.71B 314M Sep/2026
Canopy Growth CAD 28.61M 6.21M Jun/2026
Cipla INR 32.66B 361.1M Sep/2026
Corcept Therapeutics USD 21.92M 7.01M Sep/2026
Drreddys Laboratories INR 36.08B 13.72B Sep/2026
GlaxoSmithKline GBP 15.63B 1.29B Sep/2026
Hikma Pharmaceutical USD 715M 104M Dec/2025
Lonza CHF 471M 3M Dec/2024
Novartis USD 4.24B 15M Sep/2026
Pacira USD 17.5M 4K Sep/2026
Phibro Animal Health USD 136.45M 9.13M Sep/2026
Prestige Brands USD 44.02M 7.17M Sep/2026
Richter Gedeon HUF 40.28B 1.39B Jun/2026
Sun Pharmaceuticals INR 74.19B 851.6M Sep/2026
Supernus Pharmaceuticals USD 8.52M 2.92M Sep/2026
Teva Pharmaceutical Industries USD 2.55B 170M Sep/2026